...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >DESIGN AND DEVELOPMENT OF AMBROXOL HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLETS
【24h】

DESIGN AND DEVELOPMENT OF AMBROXOL HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLETS

机译:盐酸氨溴索缓释基质片剂的设计与开发

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In. the. present. investigation,. an. attempt. was. made. to. formulate. the. oral. sustained. release.matrix. tablets. of.Ambroxol. HCl. in. order. to. improve.efficacy,. reduce. the. frequency.of. administration,. and.better. patient. compliance..Ambroxol.Hydrochloride. is. a. potent. mucolytic. agent. capable. of.inducing.bronchial. secretions. used.in. the.treatment.of.respiratory.disorders..Differential.scanning.calorimetric.analysis. confirmed.the. absence. of.any.drug.polymer.interaction..Matrix.tablets.of.Ambroxol.Hydrochloride.were.formulated.employing.hydrophilic.polymers.HPMC.K100M,.Carbopol.934P.and.hydrophobic.polymer.Ethyl.cellulose. as.release.retardant.polymers...The.powder.blend.was.evaluated.for.micromeritic.properties..The.sustained.release.matrix.tablets.were.prepared.by.direct.compression. technique.. The. tablets. were. evaluated. for. thickness,. diameter,. weight.variation.test,.hardness,.friability,.and.drug. content..The.in. vitro.drug.release.characteristics.were.studied.in.simulated.gastric. fluid.(2.hours).and.intestinal.fluid.for. a.period. of.10.hours.using. USP.type.II.dissolution. apparatus.(total.12hours)..The.results.of. dissolution. studies.indicated.that.formulation.F7.(drug.to.polymer.1:0.26),.the.most.successful.of.the.study.and.exhibited.satisfactory.drug.release.in.the.initi al.hours.and.the.total.release.was.very.close.to.the.theoretical.release.profile..Matrix.tablet.containing.Ethyl.cellulose.(F7). formulation.were. found.to.show.good.initial.release.24.24%.at.2.hrs.and.at.the.end.of.12.hrs.the.drug.release.was.found.to.be.96.86%...The.n.value.for.F7.obtained.from.Korsmeyer.–.peppas.model.confirmed.that.the.drug.release.was.anomalous.diffusion.mechanism..
机译:在。的。当下。调查。一个。尝试。是。制作。至。制定。的。口服。持续。 release.matrix。平板电脑。氨溴索盐酸。为了。至。提高效率。降低。的。频率行政,。更好。患者。合规性。盐酸氨溴索。是。一种。有力的。粘液溶解。代理商。能。诱导支气管分泌物。用在呼吸障碍的差示扫描量热分析确认的缺席。使用亲水性聚合物HPMC.K100M,Carbopol.934P和疏水性聚合物。乙基纤维素配制了任何与药物相互作用的基质片剂。作为缓释聚合物,对粉末状微粉的性能进行了评估,并通过直接压缩制备了缓释基质片剂。技术..平板电脑。是。评估。对于。厚度,。直径,。重量变化测试,硬度,易碎性和药物。内容在模拟的胃中研究了体外药物释放特性。液体(2小时)和肠道液体一段时间。长达10小时的使用时间。 USP II型溶解。仪器(总共12小时)。解散。研究表明,配方F7(药物与聚合物的比例为1:0.26)是最成功的研究方法,并且在开始时就显示出令人满意的药物释放效果。每小时的总释放量与含有乙基纤维素(F7)的理论释放曲线非常接近。制定。发现在24小时内显示出良好的初始释放24.24%,并且在12小时药物释放结束时发现到96.86。从Korsmeyer – Peppas模型获得的F7的n值%证实,药物释放具有异常的扩散机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号